ZW Data Action Technologies Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ZW Data Action Technologies Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $46.63M | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | $34.75M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $32.27M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $37.61M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $29.93M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $46.40M | Jun 17, 2014 |
| FY2012 | Dec 31, 2011 | $28.11M | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | $40.42M | Apr 16, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.61M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $15.44M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $30.59M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $26.24M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $47.33M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $38.41M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $58.08M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $57.15M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $46.63M | Apr 15, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $446.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($436.0K) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($194.0K) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $98.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $632.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $5.50M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $2.42M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.61M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $7.75M | Apr 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.77M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.76M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($5.97M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($9.79M) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | ($2.75M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($5.22M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($1.26M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($14.03M) | May 27, 2020 |
| FY2018 | Dec 31, 2017 | ($10.13M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($6.49M) | Apr 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.95M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.76M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($6.01M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($11.12M) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | ($13.59M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($5.70M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($1.69M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($14.51M) | May 27, 2020 |
| FY2018 | Dec 31, 2017 | ($9.40M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($6.15M) | Apr 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $17.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $229.0K | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $326.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $539.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $869.0K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $933.0K | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.26M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $2.00M | Apr 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($929.0K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.06M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.01M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($3.19M) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | ($8.84M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $326.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($4.31M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($5.39M) | May 27, 2020 |
| FY2018 | Dec 31, 2017 | ($1.32M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($563.0K) | Apr 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $81.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $334.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
| FY2019 | Dec 31, 2018 | $11.0K | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $148.0K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $356.0K | Mar 31, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.68M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $11.23M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $19.66M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $32.63M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $20.67M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $18.55M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $16.97M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $28.56M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $30.04M | Apr 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.28M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.97M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.98M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $7.36M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $10.87M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $8.19M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $7.14M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $9.17M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $13.10M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $7.75M | Apr 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.34M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.66M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.25M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $12.30M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $21.77M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $12.55M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $11.47M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $7.84M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $15.29M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $22.24M | Apr 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $5.28M | Apr 15, 2019 |
| FY2018 | Dec 31, 2016 | $4.97M | Apr 15, 2019 |
| FY2017 | Dec 31, 2015 | $4.40M | Apr 16, 2018 |
| FY2016 | Dec 31, 2014 | $6.77M | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | $11.45M | Apr 14, 2016 |
| FY2013 | Dec 31, 2012 | $11.08M | Jun 17, 2014 |
| FY2014 | Dec 31, 2011 | $11.08M | Apr 15, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($65.22M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($63.45M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($59.69M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($53.53M) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | ($43.73M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($40.98M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($35.77M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($34.51M) | May 27, 2020 |
| FY2018 | Dec 31, 2017 | ($20.49M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($10.36M) | Apr 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $970.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $812.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $817.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $4.39M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | $7.17M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.30M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.60M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $3.74M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.95M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $3.04M | Apr 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2013 | Dec 31, 2013 | 0 | Jun 17, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Jun 17, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Apr 16, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 0 | Jun 17, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Jun 17, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Apr 16, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.27M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 2.30M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 1.93M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 7.17M | Jun 28, 2024 |
| FY2022 | Dec 31, 2021 | 7.08M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 26.06M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 19.63M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | 16.38M | May 27, 2020 |
| FY2018 | Dec 31, 2017 | 13.98M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 12.16M | Apr 16, 2018 |